Search For "glenmark pharmaceuticals"
Glenmark Pharmaceuticals receives ANDA approval for Icatibant Injection, 3
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 24 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe, the generic version of F
Read More
Glenmark launches Ryaltris®-AZ Nasal Spray for the treatment of moder
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 3 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, announced the launch of Ryaltris®-AZ Nasal Spray for the treatment of moderate to severe allergic rhinitis, in India.
Read More
Glenmark's Ryaltris® nasal spray now approved in Europe for the first
Updated : 4 years, 11 months ago IST
Mumbai (Maharashtra) [India], April 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, is concluding the final, national phase of its marketing approval application process to enable launch of its innovative nasal spray in 17 coun
Read More
Glenmark Pharma approves Rs 1,160 crore IPO from subsidiary Glenmark Life
Updated : 4 years, 11 months ago IST
Mumbai (Maharashtra) [India], Apr 19 (ANI): Glenmark Life Sciences Ltd, a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd, has filed a draft red herring prospectus with the Securities and Exchange Board of India for an initial public offer (IPO) to raise Rs 1,160 crore.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Chlorpromazine Hydroch
Updated : 5 years ago IST
Mumbai (Maharashtra) [India], March 24 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has received final approval from the United States Food & Drug Administration (US FDA) for Chlorpromazine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg, the generic v
Read More
Glenmark Pharmaceuticals receives ANDA approval for Diltiazem Hydrochlorid
Updated : 5 years ago IST
Mumbai (Maharashtra) [India], March 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Diltiazem Hydrochloride Extended-Release Capsules USP, 60 mg, 90 mg, and 120 mg, the generic ver
Read More
Glenmark and Bausch Health join hands to commercialise RYALTRIS nasal spra
Updated : 5 years ago IST
Mumbai (Maharashtra) [India], March 22 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced that its subsidiary Glenmark Specialty S.A. in Switzerland and an affiliate of Bausch Health Companies Inc. have entered into an exclus
Read More
Glenmark receives 'India Pharma Innovation of the Year' Award from the gov
Updated : 5 years ago IST
Mumbai (Maharashtra) [India], February 25 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today received the "India Pharma Innovation of the Year" award, as part of the India Pharma & India Medical Device Awards 2021.
Read More
Glenmark's Ryaltris- innovative single nasal spray, ready to market in Rus
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], February 22 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty SA, received marketing approval from the Ministry of Health of the Russ
Read More
Glenmark launches SUTIB (Sunitinib) - priced 96% lower than the innovator
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], February 16 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today launched SUTIB, the generic version of Sunitinib oral capsules to treat kidney cancer in India.
Read More
Glenmark's consolidated net profit rises by 30.05% to Rs. 2481.79 Mn. in Q
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], February 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the third quarter ended December 31 of the financial year 2020-21.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], February 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food and Drug Administration (U.S. FDA) for Clindamycin Phosphate Gel USP, 1 per cent, the generic version of Cleocin T® Gel, 1 per ce
Read More